KIORA PHARMACEUTICALS, INC. Operating Lease, Weighted Average Discount Rate, Percent
KIORA PHARMACEUTICALS, INC. (KPRX) had Operating Lease, Weighted Average Discount Rate, Percent of 5.93% as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-08-07
- 2026-06-30: Operating Lease, Weighted Average Discount Rate, Percent 5.93%.
- 2026-03-31: Operating Lease, Weighted Average Discount Rate, Percent 5.94%.
- 2025-09-30: Operating Lease, Weighted Average Discount Rate, Percent 6.12%.
- 2025-06-30: Operating Lease, Weighted Average Discount Rate, Percent 6.12%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2026-06-30 | 5.93% 10-Q · filed 2026-08-07 |
| 2026-03-31 | 5.94% 10-Q · filed 2026-05-08 |
| 2025-09-30 | 6.12% 10-Q · filed 2025-11-07 |
| 2025-06-30 | 6.12% 10-Q · filed 2025-08-08 |
| 2025-03-31 | 6.60% 10-Q · filed 2025-05-09 |
| 2022-09-30 | 5.31% 10-Q · filed 2022-11-09 |
| 2022-06-30 | 5.19% 10-Q · filed 2022-08-12 |
| 2022-03-31 | 4.66% 10-Q · filed 2022-07-08 |
| 2021-12-31 | 5.32% 10-Q · filed 2022-11-09 |
| 2021-03-31 | 5.32% 10-Q · filed 2022-07-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |